# Trial to Assess Chelation Therapy 2

Study · id `cardio:ct-nct02733185` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02733185](<https://clinicaltrials.gov/study/NCT02733185>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02733185

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1000 participants.

## Technical summary

Registry record NCT02733185. Randomized; triple masking; primary purpose prevention. Start 2016-10-01 (actual); primary completion 2023-06-30 (actual). Results posted on 2024-10-01.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 1000 participants (enrolled count; ClinicalTrials.gov record NCT02733185, source copy `cardio:ctgov-nct02733185-2025-03-30`, retrieved 2026-10-26)
- Started: 2016-10-01 (actual) (ClinicalTrials.gov record NCT02733185, source copy `cardio:ctgov-nct02733185-2025-03-30`, retrieved 2026-10-26)
- Primary completion: 2023-06-30 (actual) (ClinicalTrials.gov record NCT02733185, source copy `cardio:ctgov-nct02733185-2025-03-30`, retrieved 2026-10-26)
- Completion: 2023-06-30 (actual) (ClinicalTrials.gov record NCT02733185, source copy `cardio:ctgov-nct02733185-2025-03-30`, retrieved 2026-10-26)
- Results first posted: 2024-10-01 (ClinicalTrials.gov record NCT02733185, source copy `cardio:ctgov-nct02733185-2025-03-30`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02733185, source copy `cardio:ctgov-nct02733185-2025-03-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02733185-2025-03-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Trial to Assess Chelation Therapy 2
- Acronym: TACT2
- Condition: Diabetes
- Condition: Myocardial Infarction
- Intervention (Drug): disodium EDTA
- Intervention (Dietary supplement): Oral Multi Vitamins/Minerals (OMVM)
- Intervention (Drug): Placebo disodium EDTA
- Intervention (Dietary supplement): Placebo Oral Multi Vitamins/Minerals (OMVM)
- Lead sponsor: Mt. Sinai Medical Center, Miami
- Lead sponsor class: OTHER
- Collaborator: National Center for Complementary and Integrative Health (NCCIH)
- Collaborator class: NIH
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH
- Collaborator: Duke Clinical Research Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as a collaborator: National Center for Complementary and Integrative Health (NCCIH) (`cardio:org-national-center-for-complementary-and-integrative-health-04ced1`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)
- Registry lists this organization as a collaborator: Duke Clinical Research Institute (`cardio:org-duke-clinical-research-institute`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Edetate Disodium-Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical Trial (`cardio:pubmed-39141382`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Multivitamins After Myocardial Infarction in Patients With Diabetes: A Randomized Clinical Trial (`cardio:pubmed-40029647`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 426f6bfc70b1d80ef1fe4b1894987c69cb3e5b73dbef3a99293579c309078724
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
